Howard M. Stern - Concepedia

Author

Howard M. Stern

Infinity Pharmaceuticals (United States)

Also Known As

H M Stern, H STERN, H Stern, H. Stern, Howard M Stern, Howard M. Stern, Howard Marvin Stern, Howard Stern, Howard Stern (383250), Howard M. Stern

189

Publications

11.8K

Citations

H-Index

121

Concepts

All Affiliations

Infinity Pharmaceuticals (United States)The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Sarah Cannon Brigham and Women's Hospital

About

Howard M. Stern is an author at Infinity Pharmaceuticals (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	33	7K
2	Engineering	4	4	1.7K
3	Natural Sciences	4	4	583
4	Health Sciences	1	1	18
5	Public Health	1	1	10

Howard M. Stern

Publications

10.8K

Citations

H-Index

Page 1

	Year	Citations
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer Charles M. Rudin, Steffen Durinck, Eric Stawiski, Nature Genetics MedicinePathologyCancer GenomicsBronchial NeoplasmCancer Genetics	2012	1.1K
Diverse somatic mutation patterns and pathway alterations in human cancers Zhengyan Kan, Bijay S. Jaiswal, Jeremy Stinson, Nature Cancer ResearchEngineeringPathway AlterationsSomatic VariantTumor Heterogeneity	2010	1K
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells Olivier De Henau, Matthew Rausch, David A. Winkler, Nature Hematological MalignancyBlockade TherapyImmunologyImmune Checkpoint InhibitorMyeloid Cells	2016	843
A Central Role for HER3 in <i>HER2</i> -Amplified Breast Cancer: Implications for Targeted Therapy Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao, Cancer Research	2008	642
The mutation spectrum revealed by paired genome sequences from a lung cancer patient William Lee, Zhaoshi Jiang, Jinfeng Liu, Nature Paired Genome SequencesMutation SpectrumSomatic VariantTumor HeterogeneityMedicine	2010	500
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents Michael Degtyarev, Ann De Mazière, Christine Orr, The Journal of Cell Biology	2008	406
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients Zhaoshi Jiang, Suchit Jhunjhunwala, Jinfeng Liu, Genome Research EngineeringImmunologyHepatitis BPathologyGenomics	2012	350
Oncogenic ERBB3 Mutations in Human Cancers Bijay S. Jaiswal, Noelyn M. Kljavin, Eric Stawiski, Cancer Cell Somatic VariantOncogenic AgentCancer GeneticsMedicineRadiation Oncology	2013	345
TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer Susanna Stinson, Mark R. Lackner, Alex Adai, Science Signaling Tumor BiologySystems BiologyBreast OncologyMir-221/222 PromotesTrps1 Targeting	2011	312
Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation Bijay S. Jaiswal, Vasantharajan Janakiraman, Noelyn M. Kljavin, Cancer Cell Somatic VariantSomatic MutationsCell RegulationGeneticsP85α Promote Tumorigenesis	2009	286

Page 1